Shanghai Sabo Biochemical Technology Co., Ltd. is a modern, high-tech, export-oriented enterprise integrating scientific research, development, production, and operation of pharmaceutical APIs and intermediates. The company holds independent import and export rights, with over 90% of its products currently sold in the international market, covering North America, the European Union, South America, Southeast Asia, and other regions.

The company's production base includes pilot workshops, product testing centers, and production workshops that comply with GMP requirements.

The company has obtained ISO9001:2000 certification, and its core products have passed on-site audits from clients in South Africa, Europe, Japan, and South Korea. It is actively preparing for registration with the European EDQM and the U.S. FDA.

The company maintains long-term collaborations with several domestic universities and research institutions for the development of new compounds, improvement of synthesis routes, and optimization of production processes. It can swiftly initiate research projects based on market demands and efficiently transform scientific and technological achievements into productivity, laying a solid foundation for sustainable and stable development.